Dania Tx is a biotech company developing small molecule drugs to treat Acute Myeloid Leukaemia (AML) and other cancers. Our focus is on targeting a new biological mechanism regulating metabolism, thereby exploiting the fact that metabolism in cancer cells differs from that in normal cells. This broad-acting mechanism of action holds the potential for the treatment to be used across many cancer types.